1-4 of 4
Rubiul Islam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of ASTX727 (cedazuridine/decitabine) Plus Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Previously Untreated, Elderly Patients with AML Unfit for Chemotherapy

Tareq Abuasab, Guillermo Garcia-Manero, Nicholas Short, Yesid Alvarado, Ghayas C. Issa, Rubiul Islam, Abhishek Maiti, Musa Yilmaz, Nitin Jain, Lucia Masarova, Steven M. Kornblau, Elias Jabbour, Naveen Pemmaraju, Guillermo Montalban-Bravo, Sherry A. Pierce, Courtney D. DiNardo, Tapan M. Kadia, Naval Daver, Marina Konopleva, Hagop Kantarjian, Farhad Ravandi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3324–3326.
https://doi.org/10.1182/blood-2022-158566
Published: 2022
Journal Articles

Phase II Study of Cladribine, Idarubicin, Cytarabine (CLIA) Plus Gilteritinib in Patients with FLT3 Mutated Acute Myeloid Leukemia (AML)

Tareq Abuasab, Hagop Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Yesid Alvarado, Musa Yilmaz, Naveen Pemmaraju, Kelly S. Chien, Shehab Fareed Mohamed, Naval Daver, Steven M. Kornblau, Jan A. Burger, Nitin Jain, Rubiul Islam, Courtney D. DiNardo, Gautam Borthakur, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2021) 138 (Supplement 1): 2330.
https://doi.org/10.1182/blood-2021-151648
Published: 2021
Journal Articles

Cladribine Combined with Idarubicin and High-Dose AraC (CLIA2) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia

Mansour Alfayez, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Marina Y. Konopleva, MD PhD, Naval G. Daver, MD, Courtney D. DiNardo, MD MSc, Gautam Borthakur, MD, Prithviraj Bose, MD, Michael Andreeff, MD PhD, Yesid Alvarado, MD, Musa E. Yilmaz, MD, Naveen Pemmaraju, MD, Steven M. Kornblau, MD, Zeev E. Estrov, MD, Christopher B. Benton, MD, Koichi Takahashi, MD, Kiran Naqvi, MD MPH, Rebecca Slack, MS, Rubiul Islam, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD, Tapan M. Kadia, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4039.
https://doi.org/10.1182/blood-2018-99-119271
Published: 2018
Journal Articles

Omacetaxine Mepesuccinate for Patients with Higher-Risk MDS and CMML after Failure of Hypomethylating Agents: A Phase II Trial

Nicholas J Short, MD, Guillermo Garcia-Manero, MD, Kiran Naqvi, MDMPH, Steven Kornblau, MD, Koichi Takahashi, MD, Guillermo Montalban-Bravo, MD, Rita Khouri, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD, Courtney D. DiNardo, MDMSc, Yesid Alvarado, MD, Marie Ghosn, Zeev Estrov, MD, Prithviraj Bose, MD, Rubiul Islam, Xiao Dong, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2967.
https://doi.org/10.1182/blood.V130.Suppl_1.2967.2967
Published: 2017